Cargando…

Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study

Parkinson’s disease (PD) is a neurodegenerative disorder responsible for shaking, rigidity, and trouble in walking and patients’ coordination ability and physical stability deteriorate day by day. Bipolar disorder (BD) is a psychiatric disorder which is the reason behind extreme shiftiness in mood,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Md. Bipul, Islam, Md. Kobirul, Adhikary, Apurba, Rahaman, Abidur, Islam, Md. Zahidul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874170/
https://www.ncbi.nlm.nih.gov/pubmed/35221677
http://dx.doi.org/10.1177/11779322221079232
_version_ 1784657624033132544
author Hossain, Md. Bipul
Islam, Md. Kobirul
Adhikary, Apurba
Rahaman, Abidur
Islam, Md. Zahidul
author_facet Hossain, Md. Bipul
Islam, Md. Kobirul
Adhikary, Apurba
Rahaman, Abidur
Islam, Md. Zahidul
author_sort Hossain, Md. Bipul
collection PubMed
description Parkinson’s disease (PD) is a neurodegenerative disorder responsible for shaking, rigidity, and trouble in walking and patients’ coordination ability and physical stability deteriorate day by day. Bipolar disorder (BD) is a psychiatric disorder which is the reason behind extreme shiftiness in mood, and frequent mood inversion may reach too high called mania. People with BD have a greater chance of developing PD during the follow-up period. A lot of work has been done to understand the key factors for developing these 2 diseases. But the molecular functionalities that trigger the development of PD in people with BD are not clear yet. In our study, we are intended to identify the molecular biomarkers and pathways shared between BD and PD. We have investigated the RNA-Seq gene expression data sets of PD and BD. A total of 45 common unique genes (32 up-regulated and 13 down-regulated) abnormally expressed in both PD and BD were identified by applying statistical methods on the GEO data sets. Gene ontology (GO) and BioCarta, KEGG, and Reactome pathways analysis of these 45 common dysregulated genes identified numerous altered molecular pathways such as mineral absorption, Epstein-Barr virus infection, HTLV-I infection, antigen processing, and presentation. Analysis of protein-protein interactions revealed 9 significant hub-proteins, namely RPL21, RPL34, CKS2, B2M, TNFRSF10A, DTX2, HLA-B, ATP2A3, and TAPBP. Significant transcription factors (IRF8, SPI1, RUNX1, and FOXA1) and posttranscriptional regulator microRNAs (hsa-miR-491-3p and hsa-miR-1246) are also found by analyzing gene-transcription factors and gene-miRNAs interactions, respectively. Protein-drug interaction analysis revealed hub-protein B2M’s interaction with molecular drug candidates like N-formylmethionine, 3-indolebutyric acid, and doxycycline. Finally, a link between pathological processes of PD and BD is identified at transcriptional level. This study may help us to predict the development of PD among the people suffering from BD and gives some clue to understand significant pathological mechanisms.
format Online
Article
Text
id pubmed-8874170
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-88741702022-02-26 Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study Hossain, Md. Bipul Islam, Md. Kobirul Adhikary, Apurba Rahaman, Abidur Islam, Md. Zahidul Bioinform Biol Insights Original Research Parkinson’s disease (PD) is a neurodegenerative disorder responsible for shaking, rigidity, and trouble in walking and patients’ coordination ability and physical stability deteriorate day by day. Bipolar disorder (BD) is a psychiatric disorder which is the reason behind extreme shiftiness in mood, and frequent mood inversion may reach too high called mania. People with BD have a greater chance of developing PD during the follow-up period. A lot of work has been done to understand the key factors for developing these 2 diseases. But the molecular functionalities that trigger the development of PD in people with BD are not clear yet. In our study, we are intended to identify the molecular biomarkers and pathways shared between BD and PD. We have investigated the RNA-Seq gene expression data sets of PD and BD. A total of 45 common unique genes (32 up-regulated and 13 down-regulated) abnormally expressed in both PD and BD were identified by applying statistical methods on the GEO data sets. Gene ontology (GO) and BioCarta, KEGG, and Reactome pathways analysis of these 45 common dysregulated genes identified numerous altered molecular pathways such as mineral absorption, Epstein-Barr virus infection, HTLV-I infection, antigen processing, and presentation. Analysis of protein-protein interactions revealed 9 significant hub-proteins, namely RPL21, RPL34, CKS2, B2M, TNFRSF10A, DTX2, HLA-B, ATP2A3, and TAPBP. Significant transcription factors (IRF8, SPI1, RUNX1, and FOXA1) and posttranscriptional regulator microRNAs (hsa-miR-491-3p and hsa-miR-1246) are also found by analyzing gene-transcription factors and gene-miRNAs interactions, respectively. Protein-drug interaction analysis revealed hub-protein B2M’s interaction with molecular drug candidates like N-formylmethionine, 3-indolebutyric acid, and doxycycline. Finally, a link between pathological processes of PD and BD is identified at transcriptional level. This study may help us to predict the development of PD among the people suffering from BD and gives some clue to understand significant pathological mechanisms. SAGE Publications 2022-02-23 /pmc/articles/PMC8874170/ /pubmed/35221677 http://dx.doi.org/10.1177/11779322221079232 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Hossain, Md. Bipul
Islam, Md. Kobirul
Adhikary, Apurba
Rahaman, Abidur
Islam, Md. Zahidul
Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
title Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
title_full Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
title_fullStr Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
title_full_unstemmed Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
title_short Bioinformatics Approach to Identify Significant Biomarkers, Drug Targets Shared Between Parkinson’s Disease and Bipolar Disorder: A Pilot Study
title_sort bioinformatics approach to identify significant biomarkers, drug targets shared between parkinson’s disease and bipolar disorder: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874170/
https://www.ncbi.nlm.nih.gov/pubmed/35221677
http://dx.doi.org/10.1177/11779322221079232
work_keys_str_mv AT hossainmdbipul bioinformaticsapproachtoidentifysignificantbiomarkersdrugtargetssharedbetweenparkinsonsdiseaseandbipolardisorderapilotstudy
AT islammdkobirul bioinformaticsapproachtoidentifysignificantbiomarkersdrugtargetssharedbetweenparkinsonsdiseaseandbipolardisorderapilotstudy
AT adhikaryapurba bioinformaticsapproachtoidentifysignificantbiomarkersdrugtargetssharedbetweenparkinsonsdiseaseandbipolardisorderapilotstudy
AT rahamanabidur bioinformaticsapproachtoidentifysignificantbiomarkersdrugtargetssharedbetweenparkinsonsdiseaseandbipolardisorderapilotstudy
AT islammdzahidul bioinformaticsapproachtoidentifysignificantbiomarkersdrugtargetssharedbetweenparkinsonsdiseaseandbipolardisorderapilotstudy